Global Veterinary Vaccine Market Growth 2025-2031

The global Veterinary Vaccine market size is predicted to grow from US$ 12120 million in 2025 to US$ 18400 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Factors influencing growth in demand for farm vaccines include:

• human population growth and increasing standards of living, particularly in many emerging markets;

• increasing demand for improved nutrition, particularly animal protein;

• natural resource constraints, such as scarcity of arable land, fresh water and increased competition for cultivated land, resulting in fewer resources that will be available to meet this increased demand for animal protein;

• increasing urbanization and increased focus on food safety and food security. Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally.

The primary companion animal species are dogs, cats and horses. Factors influencing growth in demand for companion animal vaccines include:

• economic development and related increases in disposable income, particularly in many emerging markets;

• increasing pet ownership

• companion animals living longer, increasing medical treatment of companion animals and advances in companion animal medicines and vaccines.

North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 30%.

Global key Veterinary Vaccine players cover Merck, Boehringer Ingelheim, Zoetis, Elanco, Ceva, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Virbac, etc. In terms of revenue, the global five largest companies occupied for a share nearly 75.64% in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Veterinary Vaccine Industry Forecast” looks at past sales and reviews total world Veterinary Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Vaccine sales for 2025 through 2031. With Veterinary Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Live Attenuated Vaccines
Inactivated Vaccines
Other

Segmentation by Application:
Farm Animal
Companion Animal

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
Medion
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI

Key Questions Addressed in this Report

What is the 10-year outlook for the global Veterinary Vaccine market?

What factors are driving Veterinary Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Veterinary Vaccine market opportunities vary by end market size?

How does Veterinary Vaccine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.